Anavex life sciences to present at the 2021 cantor virtual global healthcare conference

New york, sept. 20, 2021 (globe newswire) -- anavex life sciences corp. (“anavex” or the “company”) (nasdaq: avxl), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including alzheimer's disease, parkinson's disease, rett syndrome and other central nervous system (cns) disorders, today announced that christopher u. missling, phd, president and chief executive officer of anavex, will present at the 2021 cantor virtual global healthcare conference on monday, september 27, 2021 at 10:40 am (et). the conference is being held september 27-30, 2021.
AVXL Ratings Summary
AVXL Quant Ranking